Checking inhaler use with a smart spacer for severe asthma on biologics
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests if a smart spacer can help people with severe asthma use their inhaler correctly and stick to their medication schedule. It’s for adults already taking biologic drugs for asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with severe asthma that is hard to control
- You take biologic medicines for your asthma (like omalizumab or dupilumab)
- You use a metered-dose inhaler (puffer) with a spacer for your daily asthma medications
- You can read and understand Dutch
- You are not currently pregnant and are not terminally ill
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether an asthma care program with digital (phone-based) support helps people with severe asthma stay more stable and manage symptoms better. You may need to meet specific criteria for “severe, refractory” asthma and be willing to use a smartphone for monitoring and coaching.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
This study tests if using a small smart device with your Trimbow inhaler helps you use it correctly and take it as prescribed. It is for people with asthma who already use Trimbow.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
This trial tests a new medicine, QL2302, to see how well it works compared to an approved treatment called Tezspire for people with severe asthma. If you have asthma that is not well controlled despite using daily inhalers and other medications, you may be able to join.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.